Adjuvant interferon-based chemoradiation followed by gemcitabine for resected pancreatic adenocarcinoma

Annals of Surgery

Volumn 249, Issue 5, 2009, Pages 865-

  Saidi, Reza F ^a   Jacobs, Michael J ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b PROVIDENCE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA INTERFERON RECEPTOR; BETA INTERFERON RECEPTOR; CISPLATIN; FLUOROURACIL; GEMCITABINE; INTERFERON; INTERFERON RECEPTOR; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; DRUG DERIVATIVE;

ADJUVANT THERAPY; APOPTOSIS; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; DRUG CYTOTOXICITY; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; LETTER; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; MULTIMODALITY CANCER THERAPY; NOTE; PANCREAS RESECTION; PANCREAS TUMOR;

ADENOCARCINOMA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; HUMANS; INTERFERONS; PANCREATECTOMY; PANCREATIC NEOPLASMS; RADIOTHERAPY, ADJUVANT;

EID: 67649522510     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181a42218     Document Type: Letter

References (6)

1. Linehan DC, Tan MC, Strasberg SM, Drebin JA, Hawkins WG, Picus J, Myerson RJ, Malyapa RS, Hull M, Trinkaus K, Tan BR Jr. Adjuvant interferon-based chemoradiation followed by gemcitabine for resected pancreatic adenocarcinoma: a single-institution phase II study. Ann Surg. 2008; 248:145-151.
2. Saidi RF, Williams F, Ng J, Danquah G, Mittal VK, ReMine SG, Jacobs MJ. Interferon receptors and the caspase cascade regulate the antitumor effects of interferons on human pancreatic cancer cell lines. Am J Surg. 2006;191:358-363.
3. Vitale G, van Eijck CH, van Koetsveld Ing PM, Erdmann JI, Speel EJ, van der Wansem Ing K, Mooij DM, Colao A, Lombardi G, Croze E, Lamberts SW, Hofland LJ. Type I interferons in the treatment of pancreatic cancer: mechanisms of action and role of related receptors. Ann Surg. 2007;246:259-268.
4. Saidi RF, Williams F, Silberberg B, Mittal VK, ReMine SG, Jacobs MJ. Expression of interferon receptors in pancreatic cancer: identification of a novel prognostic factor. Surgery. 2006;139:743- 748.
5. Saidi RF, Remine SG, Jacobs MJ. Interferon receptor alpha/beta is associated with improved survival after adjuvant therapy in resected pancreatic cancer. HPB (Oxford). 2007;9:289-294.
6. Picozzi VJ, Kozarek RA, Traverso LW. Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am J Surg. 2003;185:476- 480.